ARTICLE | Clinical News
Targretin bexarotene capsules regulatory update
April 9, 2001 7:00 AM UTC
Europe granted marketing approval of LGND's Targretin capsules to treat advanced stage cutaneous T cell lymphoma (CTCL) refractory to at least one systemic treatment. Also, LGND submitted an applicat...